Salvina Therapeutics
Allschwil
About Salvina Therapeutics
Salvina Therapeutics is working to break through efficacy barriers in inflammatory and autoimmune illnesses. The business discovered a novel epitope for specifically targeting TNF, culminating in the development of antibodies with a novel mode of action.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $544.7K
- Last round: Grant (Oct 2023)
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/salvina-therapeutics-52334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.